Immunotherapy of tumors with vaccines based on xenogeneic homologous molecules

Anti-Cancer Drugs

Volumn 13, Issue 3, 2002, Pages 229-235

  Wei, Yu Quan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Cancer vaccine; Gene therapy; Immune tolerance; Xenogeneic homologous gene

Indexed keywords

ANTIGEN; BETA3 INTEGRIN; CANCER VACCINE; GROWTH FACTOR; GROWTH FACTOR RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CROSS REACTION; GENE SEQUENCE; GENE THERAPY; HOMOLOGOUS RECOMBINATION; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SOLID TUMOR; T LYMPHOCYTE; TUMOR GROWTH;

ANIMALS; CANCER VACCINES; HUMANS; IMMUNOTHERAPY; NEOPLASMS;

EID: 0036250640     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200203000-00004     Document Type: Short Survey

References (48)

1. Cancer vaccines: Basic principles
2. Tumor antigens recognized by T cells
3. Progress in human tumor immunology and immunotherapy
4. In situ observation of inflammatory cell-tumor cell interaction in human seminoma (germinoma)
5. Direct ultrastructural evidence of lymphocyte-mediated cancer cell lysis in the microenvironments of Chinese nasopharygeal carcinomas
6. In situ observation of inflammatory cell-tumor cell interaction in human lung carcinoma
7. Induction of autologus tumor killing by heat treatment of fresh human tumor cells: Involvement of γ/δ T cells and Heat shock protein(HSP)70
8. Accumulation of γ/δ T cell in human dysgerminoma and seminoma: Roles in autologous tumor cell killing activity and the formation of granuloma
9. Impairment of host immunity by surgical stress and its prevention by urinastin
10. The investigation of autologous tumor-killing activity in human tumors
11. Biological and clinical significance of autologous tumor-killing activity in human cancer and its induction therapy
12. Autologous tumor killing activity and adoptive immunotherapy
13. Effective tumor vaccine gene rated by fusion of hepatoma cells with activated B cells
14. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine
15. Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen
16. Immunotherapy of melanoma with xenogeneic melanocytes
17. 3
18. What is the evidence that tumors are angiogenesis dependent?
19. Mechanism of angiogenesis
20. Controlling the vasculature: Angiogenesis anti-angiogenesis and vascular targeting of gene therapy
21. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium
22. A new alternative transcript encodes a 60 kDa truncated form of integrin beta 3
23. Molecular cloning of Quek 1 and 2 two quail vascular endothelial growth factor (VEGF) receptor-like molecules
24. Transforming growth factor β1 down-regulates vascular endothelial growth factor receptor 2/fik-1 expression in vascular endothelial cells
25. 3-mediated human endothelial cell adhesion and calcium signaling
26. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-endoded domain
27. Vascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGF
28. Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells
29. v integrins during angiogenesis: Insights into potential mechanisms of action and clinical development
30. 3-ligand interaction. Identification of a heterodimeric RGD binding site on the vitronectin receptor
31. 3 integrin bind allosteric to the ligand binding site and induce ligand dissociation
32. Neovascularization of the Xenopus embryo
33. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
34. Vascular endothelial growth factor is a secreted angiogenic mitogen
35. Vascular-specific growth factors and blood vessel formation
36. Angiogenesis in cancer and other diseases
37. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells
38. Gene therapy for cancer: What have we done and where are we going?
39. Simultaneous blockage of different EGF-like growth factors results in efficient growth inhibition of human colon carcinoma xenografts
40. Expression and regulation of c-erbB ligands in human and neck squamous carcinoma cells
41. Interleukin-6 in multiple myeloma and related plasma cell dyscrasias
42. Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes
43. h2 immunity
44. h2 paradigm
45. T cell selection and autoimmunity: Flexibility and tuning
46. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE)
47. + T cells are required for the development of experimental autoimmune gastritis
48. The Drosophila genome sequence: Implications for biology and medicine